##common.pageHeaderLogo.altText##

Vol. 3 No. 6 (2023)

Using Gene Expression Profiling, İdentify Genetic Changes İn Multiple Sclerosis (MS) And Determine Molecular Pathways

Clinical Medicine And Health Research Journal, Vol. 3 No. 6 (2023), 2 December 2023 , Page 703-708
https://doi.org/10.18535/cmhrj.v3i6.286

Abstract

Aim: In this study, an open-access dataset of RNAseq data from proggressive multiple sclerosis (MS) samples and matched normal-appearing white matter (NAWM) samples was used to identify genetic alterations that play a role in the development of MS, the prevalence is on the rise in both industrialized and emerging nations.


Material and methods: The dataset utilized in this investigation comprises nine samples of lesions and corresponding samples of NAWM tissue. The gene expression analysis was conducted on the dataset using the limma package in the R programming language. The clusterProfiler software was utilized to do enrichment analysis.


Results: 493 genes showed different up- or down-regulation in lesion tissues compared to NAWM tissues. According to the results of the enrichment analysis with these genes, the processes that play a role in progressive MS cancer are intracelluler anatomical structure, membrane bounded organelle, non-membrane bounded organelle, intracelluler non-membrane bounded organelle.


Conclusion: As a result, it can be said that the genetic structure of progressive MS tissues (lesion) changes compared to NAWM tissues, with the information obtained from gene expression analysis and enrichment analysis. It might be argued that the therapeutic efficacy of the disease can be enhanced by the comprehensive and diverse analysis of biomarkers.

Keywords:
  • Multiple sclerosis (MS), genetic alteration, gene expression analysis, bioinformatics

How to Cite

Kucukakcali, Z. ., & Balikci Cicek, I. . (2023). Using Gene Expression Profiling, İdentify Genetic Changes İn Multiple Sclerosis (MS) And Determine Molecular Pathways. Clinical Medicine And Health Research Journal, 3(6), 703–708. https://doi.org/10.18535/cmhrj.v3i6.286

Download Citation

References

  • Dimitrov LG, Turner B. What's new in multiple sclerosis? The British journal of general practice : the journal of the Royal College of General Practitioners. 2014;64(629):612-3.
  • Nicholas R, Rashid W. Multiple sclerosis. American family physician. 2013;87(10):712.
  • Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, et al. Environmental and genetic risk factors for MS: an integrated review. Annals of clinical and translational neurology. 2019;6(9):1905-22.
  • Dobson R, Giovannoni G. Multiple sclerosis–a review. European journal of neurology. 2019;26(1):27-40.
  • Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, et al. Secondary Progressive Multiple Sclerosis: New Insights. Neurology. 2021;97(8):378-88.
  • Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R. Age-specific effects of childhood body mass index on multiple sclerosis risk. Journal of Neurology. 2022;269(9):5052-60.
  • Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. The Lancet Neurology. 2004;3(2):104-10.
  • Vandebergh M, Degryse N, Dubois B, Goris A. Environmental risk factors in multiple sclerosis: Bridging Mendelian randomization and observational studies. Journal of Neurology. 2022;269(8):4565-74.
  • Price E, Lucas R, Lane J. Experiences of healthcare for people living with multiple sclerosis and their healthcare professionals. Health expectations : an international journal of public participation in health care and health policy. 2021;24(6):2047-56.
  • Yang X, Wu Y, Zhang B, Ni B. Noncoding RNAs in multiple sclerosis. Clinical epigenetics. 2018;10(1):1-12.
  • Akalın PK. Introduction to bioinformatics. Molecular nutrition & food research. 2006;50(7):610-9.
  • van Hal NL, Vorst O, van Houwelingen AM, Kok EJ, Peijnenburg A, Aharoni A, et al. The application of DNA microarrays in gene expression analysis. Journal of biotechnology. 2000;78(3):271-80.
  • Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(43):15545-50.
  • Smyth GK. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor: Springer; 2005. p. 397-420.
  • Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The innovation. 2021;2(3).
  • Amato MP, Derfuss T, Hemmer B, Liblau R, Montalban X, Soelberg Sørensen P, et al. Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop. Multiple sclerosis (Houndmills, Basingstoke, England). 2018;24(5):590-603.
  • Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell. 2018;175(6):1679-87.e7.
  • Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nature reviews Neurology. 2017;13(1):25-36.
  • Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, et al. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis. Acta neuropathologica communications. 2019;7(1):1-17.
  • Lerma-Martin C, Badia-i-Mompel P, Ramirez Flores RO, Sekol P, Hofmann A, Thäwel T, et al. Spatial cell type mapping of multiple sclerosis lesions. bioRxiv. 2022:2022.11. 03.514906.]
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information